Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,590 | 258 | 61.7% |
| Travel and Lodging | $2,292 | 6 | 30.8% |
| Education | $557.44 | 12 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROCEPT BioRobotics Corporation | $2,787 | 15 | $0 (2024) |
| Astellas Pharma US Inc | $1,042 | 63 | $0 (2023) |
| Janssen Biotech, Inc. | $749.97 | 39 | $0 (2023) |
| ABBVIE INC. | $321.05 | 21 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $311.81 | 16 | $0 (2022) |
| PFIZER INC. | $282.24 | 17 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $281.62 | 17 | $0 (2023) |
| COLOPLAST CORP | $240.47 | 15 | $0 (2024) |
| Boston Scientific Corporation | $185.48 | 11 | $0 (2023) |
| 180 Medical, Inc. | $147.51 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.42 | 2 | PROCEPT BioRobotics Corporation ($27.76) |
| 2023 | $3,751 | 62 | PROCEPT BioRobotics Corporation ($2,760) |
| 2022 | $822.08 | 43 | Astellas Pharma US Inc ($259.33) |
| 2021 | $627.59 | 39 | Astellas Pharma US Inc ($157.61) |
| 2020 | $432.68 | 24 | Janssen Biotech, Inc. ($216.42) |
| 2019 | $605.71 | 37 | Astellas Pharma US Inc ($197.35) |
| 2018 | $556.65 | 37 | Astellas Pharma US Inc ($218.03) |
| 2017 | $597.31 | 32 | Janssen Products, LP ($99.99) |
All Payment Transactions
276 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $27.76 | General |
| Category: UROLOGY | ||||||
| 02/20/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Continence Care | ||||||
| 12/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Urology | ||||||
| 11/28/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Continence Care | ||||||
| 11/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Oncology | ||||||
| 10/26/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Urology | ||||||
| 10/12/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: HORMONE THERAPY | ||||||
| 10/07/2023 | Boston Scientific Corporation | Tria Firm (Device) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Tria_URO | ||||||
| 09/28/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Urology | ||||||
| 09/22/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: HORMONE THERAPY | ||||||
| 08/31/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/30/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $103.14 | General |
| Category: Urology | ||||||
| 08/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Urology | ||||||
| 08/29/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Oncology | ||||||
| 08/28/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: Prostate cancer | ||||||
| 08/15/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Urology | ||||||
| 08/15/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: Urology | ||||||
| 08/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Urology | ||||||
| 07/24/2023 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $20.34 | General |
| 07/19/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Urology | ||||||
| 07/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Oncology | ||||||
| 07/17/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,694 | 2,411 | $414,122 | $151,307 |
| 2022 | 21 | 1,782 | 2,352 | $317,467 | $132,638 |
| 2021 | 29 | 1,868 | 2,386 | $396,926 | $165,139 |
| 2020 | 31 | 2,031 | 2,959 | $513,795 | $203,387 |
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 424 | $80,984 | $35,957 | 44.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 141 | 201 | $80,802 | $29,976 | 37.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 23 | 172 | $90,128 | $22,851 | 25.4% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 16 | 20 | $18,660 | $8,447 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 156 | $20,904 | $8,339 | 39.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 23 | 26 | $17,498 | $7,743 | 44.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 38 | 38 | $15,960 | $6,056 | 37.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 59 | 59 | $19,262 | $5,509 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 32 | $8,544 | $3,955 | 46.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 66 | $6,864 | $3,651 | 53.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 38 | 44 | $12,348 | $3,469 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 32 | $6,336 | $2,823 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,422 | $2,574 | 40.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 155 | 224 | $7,168 | $1,593 | 22.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 39 | $2,340 | $1,423 | 60.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 283 | 405 | $2,835 | $1,378 | 48.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,783 | $1,285 | 34.0% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 21 | 22 | $4,752 | $1,083 | 22.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 49 | 52 | $2,080 | $959.40 | 46.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 33 | $1,782 | $794.31 | 44.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 12 | 13 | $1,755 | $584.45 | 33.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 117 | 177 | $1,593 | $524.36 | 32.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 70 | 86 | $602.00 | $184.95 | 30.7% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 38 | 39 | $468.00 | $86.31 | 18.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 12 | 12 | $252.00 | $63.34 | 25.1% |
About Dr. Patrick Ellison, M.D
Dr. Patrick Ellison, M.D is a Urology healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184626244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Ellison, M.D has received a total of $7,439 in payments from pharmaceutical and medical device companies, with $46.42 received in 2024. These payments were reported across 276 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,590).
As a Medicare-enrolled provider, Ellison has provided services to 7,375 Medicare beneficiaries, totaling 10,108 services with total Medicare billing of $652,471. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Paducah, KY
- Active Since 06/02/2005
- Last Updated 04/07/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1184626244
Products in Payments
- AQUABEAM ROBOTIC SYSTEM (Device) $2,760
- ERLEADA (Drug) $588.36
- XTANDI (Drug) $426.05
- MYRBETRIQ (Drug) $322.96
- XIAFLEX (Biological) $311.81
- GEMTESA (Drug) $276.15
- LUPRON DEPOT (Drug) $214.58
- ORGOVYX (Drug) $196.20
- Myrbetriq (Drug) $148.52
- Erleada (Drug) $139.37
- ZYTIGA (Drug) $130.77
- Nubeqa (Drug) $102.91
- ELIGARD (Drug) $98.79
- Xtandi (Drug) $93.61
- SpeediCath (Device) $90.95
- Urolift - UL400 (Device) $69.58
- GENTLECATH (Device) $69.46
- VESICARE (Drug) $61.17
- Androgel (Drug) $51.79
- FIRMAGON (Drug) $48.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Paducah
Dr. Donald Spicer, M.d, M.D
Urology — Payments: $5,341
Brian Johnston, Pa, PA
Urology — Payments: $3,235
Charles Ransler, M.d, M.D
Urology — Payments: $937.65
Jenny Franke, Md, MD
Urology — Payments: $576.71
Dr. Robert Kupper, M.d, M.D
Urology — Payments: $84.84
Dr. Ronald Kupper, M.d, M.D
Urology